Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
G SharmaM N V Ravi Kumar

Abstract

Insulin loaded microemulsions were developed adopting a low shear reverse micellar approach using didoceyldimethylammonium bromide (DMAB) as the surfactant, propylene glycol (PG) as the co-surfactant, triacetin (TA) as the oil phase and insulin solution as the aqueous phase. A ternary phase diagram was constructed based on multiple cloud point titration to highlight the reverse micellar region. The droplet sizes of the microemulsions were 161.7±24.7nm with PDI of 0.447±0.076 and insulin entrapment of ∼85%. Transmission electron microscopy (TEM) revealed the spherical nature and size homogeneity of the microemulsion droplets. The conformational stability of the entrapped insulin within microemulsions was confirmed by fluorescence spectroscopy and circular dichroism. The microemulsions displayed a 10-fold enhancement in bioavailability compared with plain insulin solution administered per oral in healthy rats. The short-term in vivo efficacy in STZ induced diabetic rats provided the proof of concept by a modest glucose reduction at a dose of 20IU/kg. Together this preliminary data indicate the promise of microemulsions for oral delivery of insulin.

Citations

Oct 12, 2012·International Journal of Nanomedicine·Lidiane M MonteiroLucio M Cabral
Nov 28, 2013·International Journal of Pharmaceutics·Mengmeng NiuWei Wu
Dec 18, 2013·Therapeutic Delivery·Bharti SapraAshok K Tiwary
Feb 22, 2012·Indian Journal of Pharmacology·Hossein NajafzadehFakhri Kianidehkordi
Mar 20, 2015·Drug Delivery and Translational Research·Nilam H Patil, Padma V Devarajan
Dec 14, 2012·Journal of Microencapsulation·Fernando Cárdenas-BailónTzayhrí Gallardo-Velázquez
Oct 26, 2011·Journal of Drug Targeting·Carla G MoutinhoVictor M Balcão
Aug 18, 2012·Expert Opinion on Drug Delivery·Ping LiAnette Müllertz
Jan 4, 2013·Drug Development and Industrial Pharmacy·Sumita PaulKrutika Sawant
Feb 24, 2016·International Journal of Pharmaceutics·Nada MatouguiPatrick Saulnier
Jul 31, 2013·Nanomedicine : Nanotechnology, Biology, and Medicine·Xingwang ZhangWei Wu
Jun 14, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Fitsum F SahleReinhard H H Neubert
May 30, 2012·Nanomedicine : Nanotechnology, Biology, and Medicine·Silke KrolPiero Marchetti
Mar 1, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Mengmeng NiuWei Wu
Feb 22, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Randall J Mrsny
Oct 11, 2011·Acta Biomaterialia·Eiichi ToorisakaMasahiro Goto
Jan 1, 2014·International Scholarly Research Notices·Sajal Kumar JhaD Harinarayana
Apr 16, 2016·Advanced Drug Delivery Reviews·Zhigao NiuMaría J Alonso
Jul 31, 2013·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Fitsum F SahleReinhard H H Neubert
Jun 21, 2016·Advanced Drug Delivery Reviews·Sam MaherDavid J Brayden
Nov 1, 2016·Nanomedicine·Theodora KaramanidouCostas Kiparissides
Dec 2, 2017·The Journal of Pharmacy and Pharmacology·Ahmed GedawyCrispin R Dass
Dec 6, 2017·Drug Delivery and Translational Research·Mahendra SinghShubhini A Saraf
Jul 28, 2019·Minerva endocrinologica·Subhankar ChatterjeeJames H O'keefe
Jan 1, 2014·International Scholarly Research Notices·Samatha AkulaSrinivas Reddy Devireddy
Jan 28, 2017·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Yifei GuoXiangtao Wang
Nov 23, 2017·Frontiers in Pharmacology·Xin LiuXuehui Cai
Jul 19, 2017·AAPS PharmSciTech·Ujwala A ShindeKavita H Singh
Nov 25, 2020·Expert Opinion on Drug Delivery·Vijay MishraAlaa A A Aljabali
Dec 9, 2020·Drug Development and Industrial Pharmacy·Mariana Domingues BianchinIrene Clemes Külkamp-Guerreiro
Jan 15, 2021·Drug Discovery Today·Sunil Kumar DubeyPrashant Kesharwani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Controlled Release : Official Journal of the Controlled Release Society
Christiane DamgéNathalie Ubrich
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Yueling ZhangGuanghui Ma
Langmuir : the ACS Journal of Surfaces and Colloids
Anuj ShuklaReinhard H H Neubert
© 2021 Meta ULC. All rights reserved